The chief executive of one of the nation’s largest for-profit hospital chains will resign by early next year as the company deals with investor pushback over its corporate strategy and recent board defections. The Dallas-based company’s board also adopted a “poison pill” plan, which in effect would halt its largest institutional shareholder, Glenview Capital Management LLC, from building upon its stake.